0

Synthesis and Cardiotonic Activity of Novel Biimidazoles

D P Matthews, J R McCarthy, J P Whitten, P R Kastner, C L Barney, F N Marshall, M A Ertel, T Burkhard, P J Shea, T Kariya

J Med Chem. 1990 Jan;33(1):317-27.

PMID: 2153209

Abstract:

A series of substituted 2,2'-bi-1H-imidazoles and related analogues was synthesized and evaluated for inotropic activity. Structure-activity relationship studies based on a nonclassical bioisosteric approach indicated the necessity of a cyano group on one of the imidazole rings to obtain the desired pharmacological profile. 4(5)-Cyano-2,2'-bi-1H-imidazole (15a) was the most potent inotropic agent in the series. It produced a 25% increase in left ventricular dP/dt at 0.16 mg/kg iv (ED25% = 0.16 mg/kg) and increased left ventricular contractile force 60% at 1 mg/kg iv in anesthetized dogs. Compound 15a is a good inhibitor of type IV cyclic nucleotide phosphodiesterase isolated from dog heart having a potency similar to that of amrinone. Neither 5'-cyano-2,4'-bi-1H-imidazole (44) nor 4-cyano-2,4'-bi-1H-imidazole (48) demonstrated inotropic activity. In addition, the two possible 1,1'-dimethylcyano-2,2'-bi-1H-imidazoles (24 and 25) were inactive, indicating that an acidic NH as well as a cyano group are essential for inotropic activity.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP62749466 Amrinone Related Compound A Amrinone Related Compound A 62749-46-6 Price
qrcode